You are 100% correct. However, I think some are irked because this whole topic of deaths didn't need to be discussed. It wasn't the point of the call. We wouldn't even have had today's call were it not for yesterday's short attack. So if the agenda for the call was mostly damage control, why talk about patients in our trial dying, even though it's likely due to placebo? We lost half the MC yesterday so we can't afford nuance at a time like this. NP should have come out with a few ultra-positive talking points ("cure", Timothy Brown, dist. deal) and avoided, at all costs, saying the word "deaths" IMO.

Now, with that said, I am not concerned one iota long term. I was just hoping to close the week $7-8, not struggle for $6 because mortality is the subject of the day thanks to NP.